Home » Topics » Science » New compound

New compound
RSS

Sumitomo Dainippon Pharma presents preclinical results for DSP-0692 in cancer

May 18, 2018

IND-enabling studies initiated for Bicycle Therapeutics' BT-5528

May 18, 2018

KalVista Pharmaceuticals develops new agents for diabetic retinopathy

May 17, 2018

Recombinant Dodekin has anticancer activity alone or with checkpoint inhibitors

May 15, 2018

Search for small-molecule PD-1/PD-L1 inhibitors yields JBI-426

May 15, 2018

Tumor growth inhibition seen with Jubilant Biosys LSD1/HDAC inhibitors

May 14, 2018

Promising in vivo results for EP-055, a potential nonhormonal male contraceptive

May 11, 2018

Regeneron presents novel REGN-4018 antibody for ovarian cancer

May 10, 2018

Novel NKCC1 inhibitor reduces brain damage after ischemic stroke in mice

May 10, 2018

Novel Ironwood soluble guanylate cyclase stimulator reduces neuroinflammation

May 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...